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Background
Atopy in children with recurrent wheeze is the best pre-
dictor for persistent asthma. A high prevalence of atopy
was found in children with recurrent wheeze who were
at high risk of developing persistent asthma based on
the Asthma Predictive Index (API)[1]. A newly modified
API now includes allergic sensitization to aeroallergens
and to foods as criteria for the risk assessment of persis-
tent asthma in children with recurrent wheeze. How-
ever, associations between wheeze and atopy in the
absence of asthma have not been extensively examined.
Since atopy is considered a risk marker for asthma in
children with recurrent wheeze, we predicted that it
would not be associated with wheeze when asthma was
absent.
Materials and methods
Children in the 1995 Manitoba Birth Cohort (SAGE)
nested case-control study were assessed at age 8-10
years by a pediatric allergist both clinically and by ques-
tionnaire. Skin-prick tests to common allergens were
performed to determine the presence of atopy. Children
underwent methacholine challenge for airway hyperre-
sponsiveness. Parent-reported history of wheeze ever
was ascertained using the question “Has your child ever
had wheezing or whistling in the chest at any time in
the past?” The association between atopy and recurrent
wheeze was determined using the odds ratio (OR) and
95% confidence interval (CI).
Results
723 (404 [55.9%] boys) children were involved in this
study (mean age 9.08 ± 0.53). 246 (34.1% [149 (36.9%)
boys]) had pediatric allergist-diagnosed asthma. 236/714
(33.1%) children assessed had current wheeze based on
allergist notes and 420 (58.4%) had parent-reported
wheeze ever; these were not mutually exclusive. There
was a significant association between atopy and parent-
reported wheeze ever (OR 2.16; 95% CI 1.59-2.94), phy-
sician-noted wheeze with a cold (OR 2.23; 95% CI 1.65-
3.00) and without a cold (OR 1.82; 95% CI 1.33-2.50).
Physician-noted wheeze without a cold was more
strongly associated with atopy in girls (OR 2.41; 95% CI
1.48-3.93) compared to boys (OR 1.46; 95% CI 0.96-
2.22). In the absence of asthma, the association between
atopy and parent-reported wheeze ever, physician-noted
wheeze with a cold and without a cold was lost. Further
stratification by PC20 category did not yield significant
associations.
Conclusions
Atopy is an important diagnostic marker in the pediatric
clinical assessment of wheeze. As predicted, wheeze not
used in the diagnosis of asthma was not associated with
atopy. These results support the use of a modified API
that includes allergic sensitization to aeroallergens and
foods for its positive predictive value.
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